Enhancement of triglyceride catabolism was linked to the PPARα pathway.
Potential therapeutic implications for treating islet fibrosis were identified.
Abstract
ANXA1 promotes ISCs activation by enhancing triglyceride catabolism through the PPARα signaling pathway, suggesting a novel therapeutic target for islet fibrosis.